查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589334

心臟去颤器市场：按类型、最终用户、患者类型划分 - 2025-2030 年全球预测

Defibrillators Market by Type (External Defibrillators, Implantable Cardioverter Defibrillators), End-User (Alternate Care Facilities, Home Care Settings, Hospitals, Clinics, & Cardiac Centers), Patient Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年心臟去颤器市场规模为140.7亿美元，预计2024年将达到149.6亿美元，复合年增长率为6.77%，到2030年将达到222.7亿美元。

心臟去颤器市场包括各种用于透过向心臟发送电脉衝或电击来恢復正常心率的医疗设备。这些设备对于治疗危及生命的心律不整、心室颤动和无脉性心室心搏过速至关重要。这项需求主要源于全球心血管疾病的增加和心臟麻痹的盛行率不断增加，这使得它在紧急应变以及公共场所、医院和家庭中变得至关重要。心臟去颤器有多种形式，包括自动体外心臟去颤器(AED)、置入式除颤器和穿戴式心臟去颤器，服务于各种最终用户，包括医院、院前、救护车和家庭。

主要市场统计
基准年[2023] 140.7亿美元
预测年份 [2024] 149.6亿美元
预测年份 [2030] 222.7亿美元
复合年增长率（%） 6.77%

市场成长受到技术进步、人口老化、社会意识提高以及促进AED部署的有利政府政策等因素的影响。除颤心臟去颤器普及率低、人工智慧和机器学习的进步可实现更好的预测分析，以及可携式和心臟去颤器心臟去颤器的新兴趋势，新兴市场充满了机会。抓住这些机会的建议包括透过研发扩大产品范围，特别是在穿戴式技术方面，以及在开拓地区建立策略伙伴关係。

然而，高昂的设备成本、严格的监管核准流程以及欠发达地区缺乏认识均是成长面临的挑战。创新机会在于开发具有成本效益的模型、增强即时监控的连接性以及将心臟去颤器与远端医疗平台整合以提高可访问性和响应时间。随着向使用者友善智慧型装置的转变，市场的性质不断发展，为医疗专业人员和公众提供支援。总之，心臟去颤器市场是医疗设备产业的一个充满活力的重要组成部分，不断创新以满足全球不断增长的医疗需求，并专注于降低成本和改进技术集成，改善患者的整体治疗效果。

市场动态：快速发展的心臟去颤器市场的关键市场洞察

心臟去颤器市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 心臟病快速增加
    • 增加公共场所心臟去颤器的可用性以及相关培训和意识提升计划
    • 有利于增加心臟去颤器采用的支援法规
  • 市场限制因素
    • 对植入式和自动体外心臟去颤器应用的担忧
  • 市场机会
    • S-ICD、MRI 相容和 CRT-D 的开发正在进行中
    • 院前救护环境对自动体外心臟去颤器的需求不断增长
  • 市场挑战
    • 故障和频繁的产品召回

波特五力：驾驭心臟去颤器市场的战略工具

波特的五力框架是了解心臟去颤器市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心臟去颤器市场的外部影响

外部宏观环境因素在塑造心臟去颤器市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解心臟去颤器市场的竞争格局

心臟去颤器市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位心臟去颤器市场供应商的绩效评估

FPNV定位矩阵是评估心臟去颤器市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，描绘心臟去颤器市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，心臟去颤器市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心臟病发生率迅速增加
      • 增加公共场所心臟去颤器的可用性以及培训和意识提升计划
      • 扩大除颤心臟去颤器采用的有利支援法规
    • 抑制因素
      • 对植入式和自动外部系统心臟去颤器应用的担忧
    • 机会
      • S-ICD、MRI 相容、CRT-D 开发正在进行中
      • 院前环境对自动体外心臟去颤器的需求不断增长
    • 任务
      • 故障和频繁的产品召回
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章心臟去颤器市集：依类型

  • 体外去颤心臟去颤器
  • 植入式心臟整流去颤器心臟去颤器
    • 皮下植入式心臟整流去颤器心臟去颤器
    • 经静脉皮下植入式心臟整流去颤器心臟去颤器
      • 双心室 ICD/心臟再同步治疗心臟去颤器
      • 双腔室ICD
      • 单腔ICD

第七章心臟去颤器市场：依最终用户分类

  • 替代性照顾设施
  • 家庭护理设置
  • 医院、诊所、心臟中心
  • 院前急救现场

第 8 章依病患类型心臟去颤器市场

  • 成人用
  • 小儿科

第九章 北美和南美心臟去颤器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太除颤心臟去颤器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲心臟去颤器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AMI Italia Srl
  • Axion Ltd.
  • Baxter International Inc.
  • Bexen Cardio By Osatu S Coop
  • Biotronik SE & CoKG
  • Boston Scientific Corporation
  • CU Medical Systems, Inc.
  • GE Healthcare
  • Koninklijke Philips NV
  • LivaNova PLC
  • Mediana Co., Ltd.
  • Medtonic PLC
  • Metsis Medikal
  • MicroPort Scientific Corporation
  • Narang Medical Limited
  • Nihon Kohden Corporation
  • Olympus Corporation
  • Progetti Srl
  • Schiller AG
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • ZOLL Medical Corporation
Product Code: MRR-8A35583B11E2

The Defibrillators Market was valued at USD 14.07 billion in 2023, expected to reach USD 14.96 billion in 2024, and is projected to grow at a CAGR of 6.77%, to USD 22.27 billion by 2030.

The defibrillator market encompasses a range of medical devices used to restore a normal heartbeat by sending an electric pulse or shock to the heart. These devices are crucial in treating life-threatening cardiac dysrhythmias, ventricular fibrillation, and pulseless ventricular tachycardia. Necessity arises primarily from the global rise in cardiovascular diseases and the increasing prevalence of sudden cardiac arrests, making them vital in emergency responses and public spaces, hospitals, and homes. The application scope extends across various forms of defibrillators, including Automated External Defibrillators (AEDs), implanted defibrillators, and wearable defibrillators, catering to different end users such as hospitals, pre-hospital settings, ambulances, and households.

KEY MARKET STATISTICS
Base Year [2023] USD 14.07 billion
Estimated Year [2024] USD 14.96 billion
Forecast Year [2030] USD 22.27 billion
CAGR (%) 6.77%

Market growth is influenced by factors like technological advancements, the aging population, increased public awareness, and favorable governmental policies promoting AED deployment. Opportunities abound in emerging markets with low defibrillator penetration, advancements in AI and machine learning for better predictive analytics, and emerging trends in portable and wearable defibrillator technologies. Recommendations to capture these opportunities include expanding product offerings through R&D, especially in wearable technologies, and strategic partnerships for distribution in untapped regions.

However, growth is challenged by high device costs, stringent regulatory approval processes, and lack of awareness in underdeveloped regions. Innovative opportunities lie in developing cost-effective models, enhancing connectivity for real-time monitoring, and integrating defibrillators with telehealth platforms to improve accessibility and response times. The market's nature continues to evolve with a shift towards user-friendly, smart devices that empower both medical professionals and laypersons. In essence, the defibrillator market is a dynamic and essential component of the medical devices industry, constantly innovating to meet the growing health needs globally, with a focus on reducing costs and improving technological integration to enhance overall patient outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Defibrillators Market

The Defibrillators Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surging incidences of cardiac disorders
    • Rising availability of defibrillators in public places coupled with training and awareness programs
    • Favorable supportive regulations for increased adoption of defibrillators
  • Market Restraints
    • Concerns pertinent to application of implantable and automated external defibrillators
  • Market Opportunities
    • Ongoing development of S-ICDs and MRI-compatible and CRT-Ds
    • Emerging demand for automated external defibrillators in prehospital environment
  • Market Challenges
    • Failure or frequent product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Defibrillators Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Defibrillators Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Defibrillators Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Defibrillators Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Defibrillators Market

A detailed market share analysis in the Defibrillators Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Defibrillators Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Defibrillators Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Defibrillators Market

A strategic analysis of the Defibrillators Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Defibrillators Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AMI Italia S.r.l., Axion Ltd., Baxter International Inc., Bexen Cardio By Osatu S Coop, Biotronik SE & CoKG, Boston Scientific Corporation, CU Medical Systems, Inc., GE Healthcare, Koninklijke Philips N.V., LivaNova PLC, Mediana Co., Ltd., Medtonic PLC, Metsis Medikal, MicroPort Scientific Corporation, Narang Medical Limited, Nihon Kohden Corporation, Olympus Corporation, Progetti Srl, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Stryker Corporation, Thermo Fisher Scientific Inc., and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Defibrillators Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across External Defibrillators and Implantable Cardioverter Defibrillators. The Implantable Cardioverter Defibrillators is further studied across Subcutaneous Implantable Cardioverter Defibrillators and TransvenoSubcutaneous Implantable Cardioverter Defibrillators. The TransvenoSubcutaneous Implantable Cardioverter Defibrillators is further studied across Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators, Dual-Chamber ICDs, and Single-Chamber ICDs.
  • Based on End-User, market is studied across Alternate Care Facilities, Home Care Settings, Hospitals, Clinics, & Cardiac Centers, and Prehospital Care Settings.
  • Based on Patient Type, market is studied across Adult and Pediatric.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surging incidences of cardiac disorders
      • 5.1.1.2. Rising availability of defibrillators in public places coupled with training and awareness programs
      • 5.1.1.3. Favorable supportive regulations for increased adoption of defibrillators
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns pertinent to application of implantable and automated external defibrillators
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing development of S-ICDs and MRI-compatible and CRT-Ds
      • 5.1.3.2. Emerging demand for automated external defibrillators in prehospital environment
    • 5.1.4. Challenges
      • 5.1.4.1. Failure or frequent product recalls
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Defibrillators Market, by Type

  • 6.1. Introduction
  • 6.2. External Defibrillators
  • 6.3. Implantable Cardioverter Defibrillators
    • 6.3.1. Subcutaneous Implantable Cardioverter Defibrillators
    • 6.3.2. TransvenoSubcutaneous Implantable Cardioverter Defibrillators
      • 6.3.2.1. Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators
      • 6.3.2.2. Dual-Chamber ICDs
      • 6.3.2.3. Single-Chamber ICDs

7. Defibrillators Market, by End-User

  • 7.1. Introduction
  • 7.2. Alternate Care Facilities
  • 7.3. Home Care Settings
  • 7.4. Hospitals, Clinics, & Cardiac Centers
  • 7.5. Prehospital Care Settings

8. Defibrillators Market, by Patient Type

  • 8.1. Introduction
  • 8.2. Adult
  • 8.3. Pediatric

9. Americas Defibrillators Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Defibrillators Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Defibrillators Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AMI Italia S.r.l.
  • 3. Axion Ltd.
  • 4. Baxter International Inc.
  • 5. Bexen Cardio By Osatu S Coop
  • 6. Biotronik SE & CoKG
  • 7. Boston Scientific Corporation
  • 8. CU Medical Systems, Inc.
  • 9. GE Healthcare
  • 10. Koninklijke Philips N.V.
  • 11. LivaNova PLC
  • 12. Mediana Co., Ltd.
  • 13. Medtonic PLC
  • 14. Metsis Medikal
  • 15. MicroPort Scientific Corporation
  • 16. Narang Medical Limited
  • 17. Nihon Kohden Corporation
  • 18. Olympus Corporation
  • 19. Progetti Srl
  • 20. Schiller AG
  • 21. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 22. Stryker Corporation
  • 23. Thermo Fisher Scientific Inc.
  • 24. ZOLL Medical Corporation

LIST OF FIGURES

  • FIGURE 1. DEFIBRILLATORS MARKET RESEARCH PROCESS
  • FIGURE 2. DEFIBRILLATORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DEFIBRILLATORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DEFIBRILLATORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DEFIBRILLATORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DEFIBRILLATORS MARKET DYNAMICS
  • TABLE 7. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DEFIBRILLATORS MARKET SIZE, BY BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DEFIBRILLATORS MARKET SIZE, BY DUAL-CHAMBER ICDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DEFIBRILLATORS MARKET SIZE, BY SINGLE-CHAMBER ICDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DEFIBRILLATORS MARKET SIZE, BY ALTERNATE CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DEFIBRILLATORS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, CLINICS, & CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PREHOSPITAL CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DEFIBRILLATORS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY TRANSVENOSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2023